Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALB | P02768 | 1/20 | 0.40 |
| ▸ | DCK | P27707 | 5/20 | 0.33 |
| ▸ | EP300 | Q09472 | 1/20 | 0.32 |
| ▸ | POLG | P54098 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1033158 | 0.78 | — | — | |
| SCHEMBL9124228 | 0.77 | — | — | |
| SCHEMBL1225898 | 0.76 | ALB (0.38) | ALBDCKEP300 | |
| SCHEMBL1739594 | 0.74 | ALB (0.38) | ALBDCKEP300POLG | |
| SCHEMBL28349363 | 0.74 | ALB (0.39) | ALBDCKEP300POLG | |
| SCHEMBL17041816 | 0.74 | ALB (0.39) | ALBDCKEP300POLG | |
| SCHEMBL27757661 | 0.72 | ALB (0.38) | ALBDCKEP300POLG | |
| SCHEMBL18080744 | 0.72 | ALB (0.41) | ALBDCKEP300POLG | |
| SCHEMBL18665254 | 0.72 | ALB (0.38) | ALBDCKEP300POLG | |
| SCHEMBL27819800 | 0.72 | ALB (0.38) | ALBDCKEP300POLG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100130734-A1 | PROCESS FOR PREPARING CAPECITABINE | DR. REDDY'S LABORATORIES LTD. (IN) | 2010-05-27 | — | — | US | claimed |
| EP-2137201-A2 | PROCESS FOR PREPARING CAPECITABINE | Dr. Reddy's Laboratories Ltd. (IN) | 2009-12-30 | — | — | EP | claimed |
| WO-2008131062-A2 | PROCESS FOR PREPARING CAPECITABINE | DR. REDDY'S LABORATORIES LTD. (IN) | 2008-10-30 | — | — | WO | claimed |
| CN-1646141-B | Modified nucleosides for treating viral infections and abnormal cell proliferation | PHARMASSET LTD | 2014-06-25 | — | — | CN | disclosed |
| CN-101862345-B | Modified nucleosides for treatment of viral infections and abnormal cellular proliferation | GILEAD SCIENCES INC | 2014-06-04 | — | — | CN | disclosed |
| CN-101862345-A | The modified nucleosides that is used for the treatment of viral infection and abnormal cell proliferation | PHARMASSET LTD | 2010-10-20 | — | — | CN | disclosed |
| US-20100130734-A1 | PROCESS FOR PREPARING CAPECITABINE | DR. REDDY'S LABORATORIES LTD. (IN) | 2010-05-27 | — | — | US | disclosed |
| EP-2164856-A1 | PROCESSES RELATED TO MAKING CAPECITABINE | Synthon B.V. (NL) | 2010-03-24 | — | — | EP | disclosed |
| EP-2137201-A2 | PROCESS FOR PREPARING CAPECITABINE | Dr. Reddy's Laboratories Ltd. (IN) | 2009-12-30 | — | — | EP | disclosed |
| US-20080300399-A1 | PROCESSES RELATED TO MAKING CAPECITABINE | SYNTHON BV (NL) | 2008-12-04 | — | — | US | disclosed |
| WO-2008145403-A1 | PROCESSES RELATED TO MAKING CAPECITABINE | SYNTHON B.V. (NL) | 2008-12-04 | — | — | WO | disclosed |
| WO-2008131062-A2 | PROCESS FOR PREPARING CAPECITABINE | DR. REDDY'S LABORATORIES LTD. (IN) | 2008-10-30 | — | — | WO | disclosed |
| CN-1646141-A | Modified nucleosides for treating viral infections and abnormal cell proliferation | PHARMASSET LTD (BB) | 2005-07-27 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100130734-A1 | PROCESS FOR PREPARING CAPECITABINE | DPYD, TYMP, TYMS | ALB 1169/4885DCK 23/4885EP300 4205/4885 |
| US-20080300399-A1 | PROCESSES RELATED TO MAKING CAPECITABINE | DPYD, TYMP, TPMT | ALB 811/4885DCK 29/4885EP300 3539/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.